New method designs high-affinity, orally bioavailable peptides

For decades, a substantial number of proteins, vital for treating various diseases, have remained elusive to oral drug therapy.

Pentixapharm Acquires Target Discovery Business of Glycotope – Biotech Investments

EQS-News: Pentixapharm AG / Key word(s): Takeover Pentixapharm Acquires Target Discovery Business of Glycotope 03.07.2024 / 08:30 CET/CEST The issuer is solely responsible for the

July 4, 2024

IRA price negotiation results to be released Thursday — report

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 14, 2024

Researchers take important step toward genetic therapy for hereditary conditions

Researchers who work with tiny drug carriers known as lipid nanoparticles have developed a new type of material capable of reaching the lungs and the

March 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.